Application 214697
- Type
- NDA
- Sponsor
- ARS PHARMS OPERATION
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEFFY | EPINEPHRINE | SPRAY;NASAL | 2MG/SPRAY | Yes | Yes |
| 002 | NEFFY | EPINEPHRINE | SPRAY;NASAL | 1MG/SPRAY | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N214697-001 | NEFFY | EPINEPHRINE | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | |
| N214697-002 | NEFFY | EPINEPHRINE | 1MG/SPRAY | SPRAY / NASAL | RLD, RS | 2025-03-05 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N214697-001 | 10576156 | 2038-02-06 | Drug product | 2024-08-28 | |
| N214697-001 | 11173209 | 2038-02-06 | U-3979 | 2024-08-28 | |
| N214697-001 | 10682414 | 2039-02-06 | U-3979 | 2024-08-28 | |
| N214697-001 | 11191838 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 |
| N214697-001 | 11717571 | 2039-02-06 | U-3979 | 2024-08-28 | |
| N214697-001 | 11744895 | 2039-02-06 | U-3979 | 2024-08-28 | |
| N214697-001 | 11918655 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 |
| N214697-001 | 12324838 | 2039-02-06 | Drug product | 2025-06-20 | |
| N214697-002 | 10576156 | 2038-02-06 | Drug product | 2025-04-03 | |
| N214697-002 | 11173209 | 2038-02-06 | U-3979 | 2025-04-03 | |
| N214697-002 | 10682414 | 2039-02-06 | U-3979 | 2025-04-03 | |
| N214697-002 | 11191838 | 2039-02-06 | U-3979 | Drug product | 2025-04-03 |
| N214697-002 | 11717571 | 2039-02-06 | U-3979 | 2025-04-03 | |
| N214697-002 | 11744895 | 2039-02-06 | U-3979 | 2025-04-03 | |
| N214697-002 | 11918655 | 2039-02-06 | U-3979 | 2025-04-03 | |
| N214697-002 | 12324838 | 2039-02-06 | Drug product | 2025-06-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | NEFFY | 1MG/SPRAY | SPRAY / NASAL | RLD, RS | 2025-03-05 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | NEFFY | 1MG/SPRAY | SPRAY / NASAL | RLD, RS | 2025-03-05 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-002 | NEFFY | 1MG/SPRAY | SPRAY / NASAL | RLD, RS | 2025-03-05 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214697-002 | NEFFY | 1MG/SPRAY | SPRAY / NASAL | RLD, RS | 2025-03-05 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214697-002 | NEFFY | 1MG/SPRAY | SPRAY / NASAL | RLD, RS | 2025-03-05 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | d06236e962d9… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N214697-001 | NEFFY | 2MG/SPRAY | SPRAY / NASAL | RLD, RS | 2024-08-09 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N214697-002 | NEFFY | 1MG/SPRAY | SPRAY / NASAL | RLD, RS | 2025-03-05 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 10576156 | 2038-02-06 | Drug product | 2024-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 11173209 | 2038-02-06 | U-3979 | 2024-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 10682414 | 2039-02-06 | U-3979 | 2024-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 11191838 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 11717571 | 2039-02-06 | U-3979 | 2024-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 11744895 | 2039-02-06 | U-3979 | 2024-08-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 11918655 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214697-001 | 12324838 | 2039-02-06 | Drug product | 2025-06-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 10576156 | 2038-02-06 | Drug product | 2025-04-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 11173209 | 2038-02-06 | U-3979 | 2025-04-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 10682414 | 2039-02-06 | U-3979 | 2025-04-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 11191838 | 2039-02-06 | U-3979 | Drug product | 2025-04-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 11717571 | 2039-02-06 | U-3979 | 2025-04-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 11744895 | 2039-02-06 | U-3979 | 2025-04-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 11918655 | 2039-02-06 | U-3979 | 2025-04-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N214697-002 | 12324838 | 2039-02-06 | Drug product | 2025-06-20 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 10576156 | 2038-02-06 | Drug product | 2024-08-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 11173209 | 2038-02-06 | U-3979 | 2024-08-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 10682414 | 2039-02-06 | U-3979 | 2024-08-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 11191838 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 11717571 | 2039-02-06 | U-3979 | 2024-08-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 11744895 | 2039-02-06 | U-3979 | 2024-08-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 11918655 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214697-001 | 12324838 | 2039-02-06 | Drug product | 2025-06-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 10576156 | 2038-02-06 | Drug product | 2025-04-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 11173209 | 2038-02-06 | U-3979 | 2025-04-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 10682414 | 2039-02-06 | U-3979 | 2025-04-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 11191838 | 2039-02-06 | U-3979 | Drug product | 2025-04-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 11717571 | 2039-02-06 | U-3979 | 2025-04-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 11744895 | 2039-02-06 | U-3979 | 2025-04-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 11918655 | 2039-02-06 | U-3979 | 2025-04-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N214697-002 | 12324838 | 2039-02-06 | Drug product | 2025-06-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 10576156 | 2038-02-06 | Drug product | 2024-08-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 11173209 | 2038-02-06 | U-3979 | 2024-08-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 10682414 | 2039-02-06 | U-3979 | 2024-08-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 11191838 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 11717571 | 2039-02-06 | U-3979 | 2024-08-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 11744895 | 2039-02-06 | U-3979 | 2024-08-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 11918655 | 2039-02-06 | U-3979 | Drug product | 2024-08-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214697-001 | 12324838 | 2039-02-06 | Drug product | 2025-06-20 | 011fe1cb6892… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| neffy | EPINEPHRINE | Sportpharm LLC | 2052f9db-7d76-443b-b702-b6b499f9a4b8 | 2026-04-24 | Warnings, Adverse reactions | 214697 NDA214697 |
| neffy | EPINEPHRINE | ARS Pharmaceuticals Operations, Inc. | a1758142-a905-401d-8961-05829f51023a | 2026-04-09 | Warnings, Adverse reactions | 214697 NDA214697 |
| neffy | EPINEPHRINE | Medical Purchasing Solutions, LLC | 2d4063e8-f56c-6902-e063-6294a90a0d40 | 2025-02-03 | Warnings, Adverse reactions | 214697 NDA214697 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.